Amedisys Inc (AMED)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 2,138,710 | 2,060,170 | 1,976,240 | 1,856,970 | 1,567,200 |
| Total stockholders’ equity | US$ in thousands | 1,134,540 | 1,066,510 | 1,051,570 | 931,351 | 809,224 |
| Financial leverage ratio | 1.89 | 1.93 | 1.88 | 1.99 | 1.94 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,138,710K ÷ $1,134,540K
= 1.89
The financial leverage ratio of Amedisys Inc has shown some fluctuations over the past five years. As of December 31, 2020, the ratio was at 1.94, indicating that the company had $1.94 in debt for every dollar of equity. This ratio increased slightly to 1.99 by December 31, 2021, suggesting a higher level of financial leverage. However, by December 31, 2022, the ratio decreased to 1.88, signaling a slight reduction in leverage.
Subsequently, by December 31, 2023, the financial leverage ratio moved slightly up to 1.93, indicating a moderate increase in debt relative to equity. Finally, as of December 31, 2024, the ratio stood at 1.89, showing a slight decrease compared to the previous year.
Overall, the financial leverage ratio of Amedisys Inc has fluctuated within a narrow range over the analyzed period, suggesting a relatively stable capital structure. Investors and analysts typically assess changes in the financial leverage ratio to gauge the level of risk associated with the company's debt obligations and the potential impact on its financial health and stability.
Peer comparison
Dec 31, 2024